Globus Medical Acquires Surgimap®
September 13 2018 - 4:30PM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, today announced the acquisition of Nemaris Inc.,
a privately held company that markets and develops Surgimap®, a
leading surgical planning software platform. Surgimap® allows
healthcare professionals to simulate potential surgical outcomes
and share medical imaging globally to improve procedural workflow
and patient care.
“The acquisition of Surgimap® bolsters Globus Medical’s efforts
to advance the future of computer-assisted surgery with the goal of
improving patient outcomes,” said Chief Executive Officer Dave
Demski. “Software-enhanced solutions are critical components of the
future of computer-assisted surgery, and Surgimap® is the leading
surgical planning software technology in the spine market today. We
are very excited about the strategic fit of this acquisition, which
will allow us to further enhance the capability of our
ExcelsiusGPS® navigation and robotic system to assist surgeons in
planning complex spine procedures and placing screws more
accurately and less invasively.”
Surgimap®’s intuitive, patient specific surgical planning and
cloud-based infrastructure, with predictive algorithms and visual
guides, is licensed to most of the leading spine implant
manufacturers today to enable these customers to plan and simulate
potential surgical outcomes in the course of treating complex
deformities. The addition of Surgimap® will further
strengthen Globus Medical’s ExcelsiusGPS® platform by streamlining
workflow and enabling superior data analytics. These existing
platform features, in addition to the deep software expertise of
the Surgimap® team, are also expected to accelerate the launch of
new products in Imaging, Navigation, and Robotics.
“The acquisition will enable Globus to combine Surgimap®’s
best-in-class spine surgery planning technology with the
best-in-class robotic and navigation technology of ExcelsiusGPS®,”
said Dr. Frank Schwab, Chief of Spine, New York City, and
co-founder of Nemaris. “We think the synergies bring enormous
benefit to the entire spine community and particularly surgeons who
are interested in less invasive robotic and navigation based
procedures.”
About Globus Medical, Inc.Globus Medical, Inc.
is a leading musculoskeletal solutions company based in Audubon,
PA. The company was founded in 2003 by an experienced team of
professionals with a shared vision to create products that enable
surgeons to promote healing in patients with musculoskeletal
disorders. Additional information can be accessed
at http://www.globusmedical.com.
Safe Harbor StatementsAll statements included
in this press release other than statements of historical fact are
forward-looking statements and may be identified by their use of
words such as “believe,” “may,” “might,” “could,” “will,” “aim,”
“estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan”
and other similar terms. These forward-looking statements are based
on our current assumptions, expectations and estimates of future
events and trends. Forward-looking statements are only predictions
and are subject to many risks, uncertainties and other factors that
may affect our businesses and operations and could cause actual
results to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, factors affecting
our quarterly results, our ability to manage our growth, our
ability to sustain our profitability, demand for our products, our
ability to compete successfully (including without limitation our
ability to convince surgeons to use our products and our ability to
attract and retain sales and other personnel), our ability to
rapidly develop and introduce new products, our ability to develop
and execute on successful business strategies, our ability to
successfully integrate the operations of Nemaris and retain key
employees, our ability to comply with changing laws and regulations
that are applicable to our businesses, our ability to safeguard our
intellectual property, our success in defending legal proceedings
brought against us, trends in the medical device industry, general
economic conditions, and other risks. For a discussion of these and
other risks, uncertainties and other factors that could affect our
results, you should refer to the disclosure contained in our most
recent annual report on Form 10-K filed with the Securities and
Exchange Commission, including the sections labeled “Risk Factors”
and “Cautionary Note Concerning Forward-Looking Statements,” and in
our Forms 10-Q, Forms 8-K and other filings with the Securities and
Exchange Commission. These documents are available at www.sec.gov.
Moreover, we operate in an evolving environment. New risk factors
and uncertainties emerge from time to time and it is not possible
for us to predict all risk factors and uncertainties, nor can we
assess the impact of all factors on its business or the extent to
which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any
forward-looking statements. Given these risks and uncertainties,
readers are cautioned not to place undue reliance on any
forward-looking statements. Forward-looking statements contained in
this press release speak only as of the date of this press release.
We undertake no obligation to update any forward-looking statements
as a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contact:Brian KearnsVice President, Business
Development and Investor RelationsPhone: (610) 930-1800Email:
investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Apr 2023 to Apr 2024